Vogenx, Inc. is a clinical-stage life science and drug development company based in Durham, North Carolina. Our  focus is improving the lives of patients suffering from dysfunctions related to human metabolism.

Vogenx is actively working to discover and develop therapeutics to safely and effectively treat underserved patient populations. Our lead program is in phase 2 development for Post Bariatric Hypoglycemia (“PBH”), a form of chronic reactive hypoglycemia associated with bariatric surgery.